Telemedicine in neurology
Telemedicine Work Group of the American Academy of Neurology update
Citation Manager Formats
Make Comment
See Comments

Abstract
Purpose While there is strong evidence supporting the importance of telemedicine in stroke, its role in other areas of neurology is not as clear. The goal of this review is to provide an overview of evidence-based data on the role of teleneurology in the care of patients with neurologic disorders other than stroke.
Recent findings Studies across multiple specialties report noninferiority of evaluations by telemedicine compared with traditional, in-person evaluations in terms of patient and caregiver satisfaction. Evidence reports benefits in expediting care, increasing access, reducing cost, and improving diagnostic accuracy and health outcomes. However, many studies are limited, and gaps in knowledge remain.
Summary Telemedicine use is expanding across the vast array of neurologic disorders. More studies are needed to validate and support its use.
Glossary
- AAN=
- American Academy of Neurology;
- EDSS=
- Expanded Disability Status Scale;
- MS=
- multiple sclerosis;
- PD=
- Parkinson disease;
- PWE=
- people with epilepsy;
- TBI=
- traumatic brain injury;
- VA=
- Department of Veterans Affairs
An increasing number of patients seeking care and a shortage of neurologists have reduced access to neurologic care.1 Projections suggest that this gap will widen as the aging population expands, requiring a greater supply of neurologic care. Telemedicine has potential to help close these gaps and can provide access to individuals who may otherwise not be able to receive neurologic care due to geographic or physical (e.g., mobility) barriers. Telemedicine can also enable earlier access to specialized care, reduce patient and caregiver burden, and improve patient satisfaction. Furthermore, telemedicine may allow neurologists who would otherwise choose to work part-time or to stop practicing altogether due to various social, physical, and health factors to continue to practice full-time. In addition, telemedicine allows many neurologists to reduce/remove travel time between facilities, thus freeing up more time for evaluations and allowing them at attend remote clinics that they might not otherwise be able or choose to attend. Telemedicine uses a growing variety of technology, applications, services, and devices, including 2-way videoconferencing, data store and forward, text- and image-based communication, smartphones, personal computing devices, and wireless sensors. While lack of reimbursement has historically been a barrier to telemedicine adoption, the Centers for Medicare & Medicaid Services has recently expanded the list of Medicare-covered telehealth services for 2019, improving access to neurologic care and opening previously unavailable revenue streams for neurologists.
Stroke care via telemedicine paved the way for other telemedicine services. Initially described in 1999, telestroke services have been formally incorporated into stroke systems of care for >10 years2,3 During that time, access to care has expanded, quality of care has improved, and treatment rates for reperfusion therapy in patients with ischemic stroke have increased.2 In addition, studies have demonstrated similar rates of stroke mimics in the telestroke setting and in-person evaluations, suggesting that stroke assessment scales and imaging interpretations are equivalent between in-person and telestroke evaluations.4 Furthermore, there is evidence that telestroke is accepted among patients from varying cultures.5,6 Despite these advancements in stroke care, there are limited data for providers, patients, and payers on the appropriateness and feasibility of telemedicine in other neurologic conditions.
The objective of this review is to provide an outline of evidence-based data on the ability of telemedicine to increase access to care, to maintain diagnostic accuracy, and to achieve acceptance by patients and physicians in subspecialty settings other than stroke. This article is not meant to define the standard of care for telemedicine or to dictate where telemedicine care is appropriate but rather to provide an overview of the state of the evidence for those neurologists who are exploring or expanding their telemedicine practice. Future publications may present expert consensus or practice recommendations.
Methods
Given the limited number of randomized controlled trials and available data, a full systematic review could not be performed. Thus, the process consisted of a qualitative assessment and ranking of all identified studies and drafting of individual subsections by subspecialty experts. Potential authors were solicited from American Academy of Neurology (AAN) sections and committees. The author panel consisted of neurologists representing the major subspecialties of adult neurology from academics, private practice, and the Department of Veterans Affairs (VA) who use telemedicine in their practices. Three authors served as methodological experts for the review (P.N., H.P., M.D.O.).
The authors adopted the definition for teleneurology as “an evolving branch of telemedicine…defined as neurologic consultation at a distance, or not in person, using various technologies to achieve connectivity, including the telephone and the internet…encompassing teleconsultation, teleconferencing and tele-education” that may be clinician or patient initiated.7 A PubMed search was conducted in February 2018. The total number of references retrieved was 1,414. After references related to acute stroke were subtracted, the number was 753. The remaining references were divided into the following subspecialty categories based on the disorders evaluated: concussion with traumatic brain injury (TBI), dementia, epilepsy, headache, movement disorders, multiple sclerosis (MS), neuromuscular, and inpatient neurology. Inclusion/exclusion criteria for articles are listed in table 1, and a summary of the number of papers included or excluded is given in table 2. Although remote patient assessment through wearable devices and mobile applications is clearly important and may ultimately improve diagnostic accuracy in remote evaluations, these tools are beyond the scope of this review.
Inclusion/exclusion criteria for articles reviewed
Summary of search results by subspecialty
Subspecialties
Concussion and TBI
Concussion, or mild TBI, is commonplace, and there is a dearth of physicians to provide evaluations of patients with these types of injuries, especially in rural areas (e.g., sports injuries at rural high schools).8 Diagnosis and care of concussion is crucial to prevent additional injury, morbidity, and mortality. Although concussion and TBI are beginning to be addressed by teleneurology, data on this use are limited.9
One study compared real-time diagnosis of concussion through teleneurology with onsite diagnosis in 11 collegiate football players by using the Standardized Assessment of Concussion, the King-Devick test, and the Balance Error Scoring System. Results of the study indicated that the diagnoses were within a statistically significant level of agreement across modalities and that there was no difference in scores on testing or removal-from-play decisions.10 A third study reported that, in sideline/locker room high school sports consultations, teleneurology for concussion was beneficial and well received by patients and caregivers.11 It was most often used for return-to-play decisions and determining the need for further evaluation. However, clinicians reported a lower degree of satisfaction. Two studies demonstrated that, at 3 months after injury, counseling and education for patients with TBI over the telephone were better than in-person treatment with regard to decreasing symptom burden and impact of symptoms on daily functioning and improving quality of life.12,13 In addition, these studies found that eventual vocational status, community integration status, and general health outcomes at 3 months were found to be equivalent between in-person treatment and teleneurology. In another telephone study, patients with TBI discharged from inpatient rehabilitation units who received 7 scheduled individualized telephone interventions over a 9-month period were found to exhibit lower depression symptom severities (with greater improvements for those with a higher burden of depression symptoms at baseline) compared to patients with in-person interventions over a 1-year period.14
There also is a vast need for concussion diagnosis support in military settings. Although there are suggestions for the use of remote imaging support, diagnosis, and care, there have not been studies on the efficacy of implementation. E-mail teleconsultations were implemented in military settings to recommend care plans for individuals with mild TBI and were found to be viable.15 The Department of Defense and the VA have successfully implemented telemedicine for mild TBI diagnosis, management of symptoms, return-to-duty decisions, and care via an electronic consultation service known as the tele-TBI clinic.16 In addition, general teleconsultations, educational materials, and remote therapy are used, among other methods of telemedicine, although research on their efficacy is lacking.
Dementia
Dementia is quite amenable to remote evaluation given that a large component of examination involves the interview. Current studies in teleneurology for dementia care suggest increased access, good diagnostic accuracy, patient and provider satisfaction, and possible cost savings. While most of the studies on teleneurology for dementia that the authors reviewed mentioned the potential role of teleneurology in increasing access to dementia specialists, no single study explicitly studied increased access as an outcome measure. One study17 reported that 17 of the 30 telemedicine clinic sessions described would likely have been canceled because of time constraints if the physician had to travel to the remote site, suggesting more reliable patient access with teleneurology. Another study highlighted that transportation barriers remain for patients who have to travel long distances to rural telemedicine clinics.18
Several studies of teleneurology for dementia focused on diagnostic accuracy and reliability of the administration of common screening tests.19,–,23 Overall, diagnostic accuracy for dementia was comparable between teleneurology and in-person evaluations, with a reported 76% to 100% consistency rate, with common specific brief standardized measures being comparable between teleneurology and in-person evaluations.19,20,24,–,26
Only 1 study27 directly reported teleneurology vs in-person visit satisfaction. All the participants had experienced both teleneurology and in-person visits, and the patient-caregiver dyads reported comparable satisfaction across the 2 formats. Postencounter questionnaires or informal assessments of teleneurology (without comparison to in-person visits) indicate high satisfaction with teleneurology among patients and families,24,28,–,30 as well as providers.23,29,31
One study found no difference in 1-year rate decreases in Mini-Mental State Examination scores between in-person and teleneurology assessments, suggesting that teleneurology is at least as efficacious as in-person visits in terms of patient outcomes.32 Another found that patients who received treatment by teleneurology had significantly longer treatment duration than patients receiving in-person treatment, suggesting that compliance with visits was higher in the teleneurology group.33 One study reported that 89% of the recommendations made by a virtual memory clinic were implemented by the referring provider,31 although this was not compared to the rate from a comparable in-person group.
Few studies included a cost-benefit analysis. In 1 study comparing teleneurology for dementia care to the cost of in-person care when the dementia expert had to travel to a rural clinic, cost analysis favored teleneurology for dementia only if the expert had to travel >2 hours.34 Multiple studies reported indirect cost savings in terms of travel miles or time saved for both patients and providers. Although some just reported shorter drives without specific data,18 others reported specific savings such as an average of 213 km saved per visit27 and an average of 67 miles and 74 minutes saved per visit.30
In summary, only 7 of the 20 studies included were randomized clinical trials, limiting the interpretation of most of these findings. Going forward, better-designed studies with clear outcomes and comparison groups are needed to determine with certainty how teleneurology compares with in-person dementia care.
Epilepsy
The management of people with epilepsy (PWE) presents many unique challenges that can be successfully addressed by teleneurology. PWE often have restricted driving privileges that can hinder traveling for visits.35,–,37 Follow-up outpatient epilepsy visits often focus on description of seizure semiology initially and seizure control, adherence, antiepileptic drug side effects, and counseling more than physical examination.37 Furthermore, monitoring of serum antiepileptic drug serum levels, especially in pregnant women, may easily be done remotely.35 The AAN epilepsy and seizure quality measure lists the consideration of referral for patients with medically refractory epilepsy to specialized epilepsy centers38 that may be far from many communities.35 Specialized epilepsy centers rely on communication and referral from community physicians to integrate care during both the evaluation for resective epilepsy surgery and the provision of chronic epilepsy care. EEGs and epilepsy monitoring unit recordings can be remotely interpreted and accessed in locations that lack specialized neurophysiologists.35 Despite evidence-based recommendations, time to referral for epilepsy surgery has remained 18 to 23 years after the onset of habitual seizures.39 Earlier access to specialized centers could improve access and outcomes.
Ample evidence in the literature supports the successful use of teleneurology for PWE. One study35 demonstrated, in 74 telemedicine encounters, medication changes in 43% of patients and discussion of surgical options in 35% of patients, with a no-show rate of only 11% vs a no-show rate of 22% among the in-person seizure clinic group of the study. In a recent prospective randomized parallel study37 with 465 stable PWE randomized to in-person vs telephone visits, there was no significant difference in the number of breakthrough seizures between the groups, and patient satisfaction for telephone visits was 90%. Another study36 indicated no significant difference in number of seizures, hospitalizations, emergency room visits, or medication compliance between patients who sought care through a traditional ambulatory clinic in an academic medical center and patients who sought care through a telemedicine clinic. One study indicated that PWE perceive e-health tools as user friendly,40 possibly suggesting that teleneurology for PWE may provide an acceptable model for management. In an era of increasing medical costs, teleneurology for PWE has also demonstrated health care system cost reductions for both patients and providers.36,41
Headache
Headaches are one of the most common neurologic disorders. Because of the dearth of headache specialists, teleneurology for headache is gaining traction. In 1 study, a comparison of traditional, in-person consultations and teleneurology consultations indicated noninferiority of teleneurology visits.42 In addition, teleneurology was found to be an accurate method of diagnosing and treating nonacute headache, saving time and money, with 99% patient satisfaction. Compliance and improvement over time were not different between groups, but the teleneurology group had fewer follow-up visits.43 In a follow-up study, these patients reported satisfaction with their telemedicine experience, which was comparable to their in-person counterparts.44 In another study, the efficacy of psychophysiologic treatment through teleneurology for vascular headaches was examined in a small group, and results demonstrated that 3 of the 4 patients improved on the Headache Index, number of headache-free days, and peak headache intensity.45 Furthermore, 2 patients reported significant reductions in prophylactic and analgesic medication use after treatment. Teleneurology in the form of interviews, medical image sharing, and videoconferencing in 1 study was found to be beneficial in the diagnosis of 1 individual with migraine.46 In a pediatric population, teleneurology follow-up for headaches was found to be more convenient and cost-effective, with high patient and parent satisfaction.47 One study of a small cohort of 8 pediatric patients demonstrated that outcomes were comparable between teleneurology and in-person visits, with high satisfaction.48 In another study, teleneurology and in-person visits for migraines were also found to be equivalent with high patient approval.49 Furthermore, a review of the literature on various implementations of teleneurology found that in 3 separate studies, outcomes of teleneurology visits were comparable to those of in-person visits.50 Electronic headache diaries, on the other hand, have been shown to be more effective than traditional paper headache diaries for both the patient and the doctor.51
Although multiple studies have demonstrated favorable results in terms of noninferiority, convenience, and patient satisfaction, some studies were performed in artificial settings, did not evaluate full neurologic examinations or used a telepresenter as an extension of the physician, evaluated only a small number of patients, or examined only stable, unchanged nonacute headache, thus warranting further study for the broader headache category.
Movement disorders
Movement disorders are underrecognized, and there is a significant shortage of trained specialists.52 Teleneurology improves access to specialty care, allowing earlier diagnosis and skilled management of movement disorders,53,–,56 as well as concomitant cognitive impairment57 and psychiatric comorbidities.58,–,60
Several studies showed noninferiority of teleneurology vs in-person evaluations and assessments with standardized scales, including the Unified Parkinson's Disease Rating Scale,e1 Unified Huntington's Disease Rating Scale,e2 and the Abnormal Involuntary Movement Scale.e3 In addition, observational analysis of gait through teleneurology, even at low-bandwidth internet speeds, was found to be reliable compared with in-person evaluation.e4 Even the review of 10-second video clips of gait allowed experienced geriatricians to reliably identify gait abnormalities.e5 An evaluation of >1,000 patients, potentially with oromandibular dystonia, by a movement disorders specialist via live “cyberconsultation” showed that only 12.5% of patients had previously been diagnosed with dystonia.54 In addition, results of a study comparing observation of preschool children with movement disorders through video clips of the children and in-person observations indicated significant agreement between the 2 forms of observation.e6 Administration of the Montréal Cognitive Assessment by teleneurology in patients with Parkinson disease (PD)57,e7 and Huntington diseasee7 has also produced reliable results. One study found no significant differences in quality of care or delivery of information, counseling, and support between groups who received predictive genetic testing for Huntington disease remotely or in person, suggesting that teleneurology may improve access to this service.e8
Although diagnostic accuracy is important, demonstration of improvement in function is ideal. Two studies showed that a teleneurology evaluation for PD resulted in medication changes and referrals for therapy and support groupse9 and that changes in medical care were suggested in 93% of initial telemedicine encounters between nursing home residents and a movement disorders specialist.e10 Furthermore, for patients with PD in a long-term care facility, the average cost per visit for those examined through teleneurology was significantly lower than that for patients examined in person.e11 In addition, a 30-day program during which neurologists reviewed several self-recorded videos of patients with PD and recommended treatment changes resulted in a 7-point improvement in Unified Parkinson's Disease Rating Scale motor scores.e12 A national randomized controlled trial of teleneurology vs in-person care for patients with PD found that teleneurology house calls are feasible, with no worsening clinical outcomes, emergency room visits, hospitalizations, or caregiver burden.e13,e14 In addition, improvement in depression and anxiety in patients with PD who have received telephone-based cognitive-behavioral therapy58,59,e15 and reduction in tic frequency in patients with PD who have received behavioral teletherapy56 have also been demonstrated. Postoperative follow-up for deep brain stimulation device placement puts a significant burden on patients and families, especially in remote locations. Two studies demonstrated the effectiveness of teleneurology evaluation and remote deep brain stimulation device adjustment in patients with PD in remote areas of China.e16,e17
Two studies reported overall satisfaction with teleneurology evaluations, including greater satisfaction with convenience and accessibilitye11,e18 and reduced travel burden. Another study showed that videophone visits to educate patients about complicated medication regimens and self-management were more useful for nurses and more satisfying to patients compared with telephone-only visits.e19
The interest in telemedicine is seen in both urban and nonurban regions, with half of all participants expressing interest in a study in Australia.e20 While there was generally wide acceptance across many of the studies, there were reports of time requirementse21 and ineffective evaluations of children with complex movement and postural disorders due to poor video quality.e22 However, store-and-forward evaluation of video recordings in the latter study was successful.
Multiple sclerosis
The cumulative burden of disability in MS can make traveling to MS specialty centers increasingly difficult for patients, thus making telemedicine an attractive option. Few studies explicitly compared teleneurology with in-person visits in terms of access to health care for patients with MS. One study reported that video visits were shorter and more focused on specific topics.e23 Visits occurred in patients' homes or work and saved an average of 258 km in travel, reduced missed workdays by 65%, reduced costs of overnight lodging by 17%, and avoided airfare for 1 patient. Caregiver burden was also reduced. Another study reported that each cognitive testing session administered through teleneurology saved more than $144 in travel costs and lost wages compared with in-person testing.e24
Among studies evaluating diagnostic accuracy, 4 evaluated the accuracy of televideo-enabled administration of the Expanded Disability Status Scale (EDSS) vs in-person administration. Two of the studies conducted as a component of the VA Home Automated Telemanagement system relied on a telepresenter. One showed high correlation between remote evaluators,e25 and both showed good agreement between remote and in-person evaluators.e25,e26 Another study compared an in-person EDSS evaluation to a multimodal remote examination that included a video of previously trained participants' self-administered neurologic evaluation, as well as patient-reported questionnaires and other components.e27 There was modest agreement between conventional and multimedia formats for EDSS score ≤4.0 (κ = 0.2) and good for EDSS scores ≥4.5 (κ = 0.6). The fourth study compared an in-person EDSS evaluation with a televideo-enabled EDSS evaluation without a telepresenter and reported evaluation score agreement within 1 point for 88% of the visits.e23 While not perfect, these studies suggest that the televideo-enabled administration of the EDSS could be used for periodic follow-up assessments. One systematic review reported accurate and reliable measurement of physical activity in patients with MS,e28 including daily step count, over a range of ambulatory impairment.e29 Remote cognitive evaluation demonstrated similar scores on automated neuropsychological assessment metrics among in-office, remote in-office, and in-home testing, although scores on the Symbol Digit Modalities Test were not similar.e24
Provider and patient satisfaction was high with in-home and in-clinic teleneurology visits e23,e26 for cognitive testing,e24 health promotion, e30,e31 and home-based management.e32
Few studies evaluated the impact of teleneurology approaches on clinical outcomes such as hospitalizations, relapses, treatment adherence, and cost of care. Adherence to MS disease-modifying therapy was addressed in a series of analyses of the VA's MS Home Automated Telehealth system, showing that brief telephone-based counseling intervention leveraging principles of motivational interviewing and teleneurology home monitoring improved MS disease-modifying therapy adherence monitoring and outcomes.e33–e35
The majority (27 of 44) of the studies reviewed focused on the use of teleneurology to improve specific domains of functioning, including mood, fatigue, physical activity, and overall quality of life. One randomized controlled trial reported improvement in physical activity after a 12-week trial of internet-delivered behavioral intervention supplemented with video coaching that was sustained during a 3-month follow-up.e36 A follow-up study reported that fatigue and mood improved through the intervention.e37 Specific aspects of physical activity such as balance appear to be effectively improved through these technologies.e38 A recent Cochrane Review found low-level evidence for telerehabilitation to improve disability, fatigue, and quality of life and stated that “more robust trials are needed to build evidence for the clinical and cost effectiveness of these interventions.”e39
Neuromuscular
The domain of neuromuscular conditions is wide and ranges between common diseases such as diabetic neuropathy and rare conditions such as periodic paralysis. Management of many neuromuscular conditions such as amyotrophic lateral sclerosis requires a comprehensive multidisciplinary approach. While there is rapid advancement in diagnostic technology, diagnosing many of these conditions requires detailed neurologic examinations to identify subtle findings that may not be easily appreciated during examinations through teleneurology. Patients with known diagnoses and whose symptoms are stable may benefit from telemedicine evaluation.
Only 4 studies for teleneurology in neuromuscular disorders met the inclusion criteria. Three unblinded mixed-methods studies focusing on patients with an established amyotrophic lateral sclerosis diagnosis found that teleneurology was generally viewed favorably by patients, caregivers, and health care providers and that patients were satisfied with teleneurology treatment.e40–e42 The most common sentiment conveyed was that teleneurology removed the burdens of travel, resulting in lower stress and more comfortable interactions. Another small, unblinded study (n = 4) of patients with known advanced facioscapulohumeral muscular dystrophy found that teleneurology was acceptable among both patients and caregivers.e43 Two studies that assessed the quality of teleneurology care through patient questionnaires reported that both patients and caregivers were satisfied with the clinical care that patients received via teleneurology, although acute care issues were never discussed.e40,e41
Inpatient general neurology
There are limited data on the use of telemedicine for inpatient general neurology. Of the 22 articles about the use of teleneurology for inpatient general neurology that were reviewed by the authors, only 1 met the criteria for inclusion. This was a cohort studye44 performed in 2 small rural hospitals for all patients >12 years of age who were admitted with neurologic symptoms over a 24-week period. Patients at one of the hospitals were offered consultation with a neurologist through teleneurology. Those patients had significantly shorter stays without any difference in diagnosis, mortality, or use of inpatient hospital resources or medical services in the follow-up period compared to patients in the hospital in which teleneurology consultation was not used, suggesting that early assessment by a neurologist using teleneurology may reduce the length of hospital stay without compromising diagnostic accuracy, mortality, or resource use.
Discussion and consensus
Teleneurology allows earlier access to specialized care, reduced patient and caregiver burden, and improved patient satisfaction. Although strong evidence supports the role of teleneurology in some subspecialties such as stroke, in part because of more immediate outcomes and often more concrete acute cost-savings, the role of teleneurology in other subspecialties of neurology is less developed.
Studies across multiple specialties report noninferiority of evaluations by telemedicine compared with traditional, in-person evaluations in terms of patient and caregiver satisfaction. However, many studies are limited, and gaps in knowledge remain (table 3). Few studies examined the benefit of having a trained telepresenter to help improve diagnostic accuracy, although it is generally accepted among members of the telemedicine community that having a telepresenter to evaluate tone, confrontational strength, sensation, postural instability, muscle hypertrophy, fundoscopy, and vestibular examination results can certainly enhance the evaluation. Conceptually, teleneurology evaluations and interventions appear to be ideal for many neurologic disorders, but there is only minimal evidence demonstrating utility in various population settings (e.g., rural, urban, suburban) and various cultures. Future studies should more systematically evaluate the accuracy of teleneurology compared to in-person visits in a larger cohort, cost and time savings, effect on clinical outcomes, and access to care.
Summary of available data across multiple quality measures of teleneurology by subspecialty
By reviewing the growing number of studies related to the practice of teleneurology here, we hope to provide insight to practicing neurologists who may decide to use telemedicine in their practice and for educators who wish to provide guidance to trainees. This article serves to inform the neurologist about the state of teleneurology initiatives and what the evidence is for these practices. While clear cut data are lacking in many aspects of teleneurology practice, this evidence base is growing.
It is important to remember that teleneurology is merely a tool by which we can deliver care. The duty to our profession and to our patients is to guide the development of teleneurology in the safest and most meaningful ways possible. Teleneurology can allow us to evaluate patients in their own homes, providing clues to safety concerns and barriers to care and a general appreciation of patients beyond their diagnoses, thus improving the patient-physician relationship. It can open communication with community providers and allow patients to stay with their local providers while improving consultation and access to specialized care or triaging to higher-acuity settings when necessary. Optimizing referral patterns and reducing patient transfers can lower health care costs for both patients and systems while improving access for those patients who require higher-level care.e45 Availability of telemedicine video visits could improve the care of patients while simultaneously converting these visits to billable encounters. As teleneurology expands, more studies are needed to validate and support its use across the vast array of neurologic disorders.
Author contributions
Dr. Hatcher-Martin: study concept and design, acquisition of data, analysis or interpretation of data, drafting/revising the manuscript, critical revision of the manuscript for important intellectual content, study supervision. Dr. Adams: analysis or interpretation of data, drafting/revising the manuscript. Dr. Anderson: study concept and design, drafting/revising the manuscript, critical revision of the manuscript for important intellectual content, study supervision. Dr. Bove: analysis or interpretation of data, drafting/revising the manuscript. Dr. Burrus: drafting/revising the manuscript. Dr. Chehrenama: analysis or interpretation of data, drafting/revising the manuscript. Ms. Dolan O'Brien: study concept and design; drafting/revising the manuscript. Dr. Eliashiv, Dr. Erten-Lyons, Dr. Giesser, Dr. Moo, Dr. Narayanaswami, Dr. Rossi, Dr. Soni, Dr. Tariq, Dr. Tsao, Dr. Vargas, and Dr. Vota: analysis or interpretation of data, drafting/revising the manuscript. Mr. Wessels: drafting/revising the manuscript. Ms. Planalp: study concept and design; drafting/revising the manuscript. Dr. Govindarajan: study concept and design, acquisition of data, analysis or interpretation of data, drafting/revising the manuscript, critical revision of the manuscript for important intellectual content, study supervision.
Study funding
This publication was developed with staff support from the AAN.
Disclosure
J. Hatcher-Martin and J. Adams report no disclosures relevant to the manuscript. E. Anderson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities from Phillips Healthcare and the law offices of Andrew Sindler and has also received compensation for serving on the Board of Directors of Corticare. R. Bove has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Roche Genentech, Novartis, EMD Serono, Biogen, Sanofi Genzyme, and Pear Digital. Dr. Bove has received research support from Akili Interactive. T. Burrus reports no disclosures relevant to the manuscript. M. Chehrenama is employed by Revance Therapeutics as senior director in neuroscience clinical development. M. Dolan O'Brien is an employee of the American Academy of Neurology. D. Eliashiv received compensation for speaking or consulting from Eisai, UCB, Sunovion, Liva Nova, Neuropace, and Greenwich. D. Erten-Lyons has received research support from Glaxo-Smith Kline and personal compensation for consulting activities from Acadia Pharmaceuticals. B. Giesser and L. Moo report no disclosures relevant to the manuscript. P. Narayanaswami has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities from Momenta Pharmaceuticals and Alexion Pharmaceuticals. Dr. Narayanaswami has received personal compensation in an editorial capacity for Muscle and Nerve. M. Rossi, M. Soni, and J. Tsao report no disclosures relevant to the manuscript. B. Vargas has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities from Amgen, Xoc Pharmaceuticals, Biohaven, Lilly, Alder, Upsher-Smith, Novartis, Teva, Allergan, Autonomic Technologies, and Promius Pharma. S. Vota has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities from Cytokinetics. S. Wessels is an employee of the American Academy of Neurology. H. Planalp was an employee of the American Academy of Neurology. R. Govindarajan reports no disclosures relevant to the manuscript. Go to Neurology.org/N for full disclosures.
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Editorial, page 16
- Received May 28, 2019.
- Accepted in final form October 6, 2019.
- © 2019 American Academy of Neurology
References
- 1.↵
- Dall TM,
- Storm MV,
- Chakrabarti R, et al
- 2.↵
- Wechsler LR,
- Demaerschalk BM,
- Schwamm LH, et al
- 3.↵
- Levine SR,
- Gorman M
- 4.↵
- Ali SF,
- Hubert GJ,
- Switzer JA, et al
- 5.↵
- 6.↵
- Al-Khathaami AM,
- Alshahrani SM,
- Kojan SM,
- Al-Jumah MA,
- Alamry AA,
- El-Metwally AA
- 7.↵
- Larner AJ
- 8.↵
- Kutcher JS,
- McCrory P,
- Davis G,
- Ptito A,
- Meeuwisse WH,
- Broglio SP
- 9.↵
- McCrory P,
- Meeuwisse WH,
- Aubry M, et al
- 10.↵
- Vargas BB,
- Shepard M,
- Hentz JG,
- Kutyreff C,
- Hershey LG,
- Starling AJ
- 11.↵
- Cardenas J,
- Zieman G,
- Erickson C
- 12.↵
- Bell KR,
- Hoffman JM,
- Temkin NR, et al
- 13.↵
- 14.↵
- 15.↵
- Yurkiewicz IR,
- Lappan CM,
- Neely ET, et al
- 16.↵
- 17.↵
- 18.↵
- Weiner MF,
- Rossetti HC,
- Harrah K
- 19.↵
- 20.↵
- 21.↵
- 22.↵
- Martin-Khan M,
- Flicker L,
- Wootton R, et al
- 23.↵
- 24.↵
- Lindauer A,
- Seelye A,
- Lyons B, et al
- 25.↵
- 26.↵
- 27.↵
- 28.↵
- 29.↵
- Tso JV,
- Farinpour R,
- Chui HC,
- Liu CY
- 30.↵
- Powers BB,
- Homer MC,
- Morone N,
- Edmonds N,
- Rossi MI
- 31.↵
- 32.↵
- Kim H,
- Jhoo JH,
- Jang JW
- 33.↵
- 34.↵
- 35.↵
- Haddad N,
- Grant I,
- Eswaran H
- 36.↵
- 37.↵
- Bahrani K,
- Singh MB,
- Bhatia R, et al
- 38.↵
- Patel AD,
- Baca C,
- Franklin G, et al
- 39.↵
- Haneef Z,
- Stern J,
- Dewar S,
- Engel J, Jr.
- 40.↵
- Leenen LAM,
- Wijnen BFM,
- de Kinderen RJA,
- van Heugten CM,
- Evers S,
- Majoie M
- 41.↵
- Reider-Demer M,
- Raja P,
- Martin N,
- Schwinger M,
- Babayan D
- 42.↵
- Muller KI,
- Alstadhaug KB,
- Bekkelund SI
- 43.↵
- Muller KI,
- Alstadhaug KB,
- Bekkelund SI
- 44.↵
- Muller KI,
- Alstadhaug KB,
- Bekkelund SI
- 45.↵
- 46.↵
- Akiyama H,
- Hasegawa Y
- 47.↵
- Qubty W,
- Patniyot I,
- Gelfand A
- 48.↵
- Vierhile A,
- Tuttle J,
- Adams H,
- tenHoopen C,
- Baylor E
- 49.↵
- Rajan B,
- Seidmann A,
- Friedman D
- 50.↵
- 51.↵
- Filipi JM,
- Khairat S
- 52.↵
- Ben-Pazi H,
- Browne P,
- Chan P, et al
- 53.↵
- 54.↵
- Yoshida K
- 55.↵
- Shore J,
- Vo A,
- Yellowlees P, et al
- 56.↵
- 57.↵
- Stillerova T,
- Liddle J,
- Gustafsson L,
- Lamont R,
- Silburn P
- 58.↵
- 59.↵
- 60.↵
- Data Available from Dryad (additional references, e-references e1–e45): doi.org/10.5061/dryad.qf36q53.
Letters: Rapid online correspondence
- Reader response: Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update
- Zhi-Feng Mao, Neurologist, KingMed Diagnostics, Guangzhou (Guangdong, China)
- Yu-Jia Wang, Rheumatologists, KingMed Diagnostics, Guangzhou (Guangdong, China)
- Tai-Peng Zhang, Neurologist, The Eighth Affiliated Hospital of Guangxi Medical University, Guigang (Guangxi, China)
Submitted February 04, 2020 - Reader response: Telemedicine in neurology: Telemedicine Work Group of the American Academy of Neurology update
- Vasudevan Devanathan, Professor of Neurology, Saveetha Medical College (Chennai, India)
Submitted December 05, 2019
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Research
High patient satisfaction with telehealth in Parkinson diseaseA randomized controlled studyJayne R. Wilkinson, Meredith Spindler, Stephanie M. Wood et al.Neurology: Clinical Practice, May 03, 2016 -
Research
Remote telemedicine evaluation of deep brain stimulation candidacyRetrospective cohort analysisNatalie Witek, Susan L. Heath, Bichun Ouyang et al.Neurology: Clinical Practice, September 11, 2019 -
Article
National randomized controlled trial of virtual house calls for Parkinson diseaseChristopher A. Beck, Denise B. Beran, Kevin M. Biglan et al.Neurology, August 16, 2017 -
Editorial
Teleneurology is neurologyAmy K. Guzik, Jeffrey A. Switzer et al.Neurology, December 04, 2019